Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-31

Clinical Trial Update: Impact of Oxytocin on Obstructive Sleep Apnea Induced Changes in Sleep [Phase 2]

View source ↗

Summary

Phase 2 trial update on the impact of oxytocin for sleep apnea–related sleep changes; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: George Washington University | Conditions: Sleep Apnea, Obstructive | Phase 2 | Status: COMPLETED | Results posted: 2023-01-31